|
Volumn 29, Issue SUPPL. 6, 2009, Pages
|
Strategies for inhibiting vascular Endothelial growth factor
|
Author keywords
Age related macular degeneration; Choroidal neovascularization; Macula; Vascular endothelial growth factor
|
Indexed keywords
BEVASIRANIB;
RANIBIZUMAB;
RAPAMYCIN;
RTP 80LI;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
VASCULOTROPIN INHIBITOR;
ANGIOGENESIS;
BIOLOGICAL THERAPY;
CLINICAL TRIAL;
DISEASE CONTROL;
DISEASE COURSE;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG TARGETING;
ENZYME INHIBITION;
HUMAN;
NOTE;
PROTEIN FUNCTION;
RETINA MACULA AGE RELATED DEGENERATION;
SIGNAL TRANSDUCTION;
AGED;
ANGIOGENESIS INHIBITORS;
CHOROIDAL NEOVASCULARIZATION;
COMBINED MODALITY THERAPY;
DRUG THERAPY, COMBINATION;
HUMANS;
MACULAR DEGENERATION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 68049127817
PISSN: 0275004X
EISSN: None
Source Type: Journal
DOI: 10.1097/IAE.0b013e3181ad240c Document Type: Note |
Times cited : (2)
|
References (8)
|